With 0.68 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.81 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $20.38 whereas the lowest price it dropped to was $19.28. The 52-week range on CON shows that it touched its highest point at $24.81 and its lowest point at $18.89 during that stretch. It currently has a 1-year price target of $27.50.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CON was down-trending over the past week, with a drop of -5.81%, but this was down by -10.40% over a month.
Float and Shares Shorts:
At present, 127.34 million CON shares are outstanding with a float of 108.81 million shares on hand for trading. On 2024-12-13, short shares totaled 3.23 million, which was 252.99999999999997 higher than short shares on 1731628800. In addition to Mr. William Keith Newton as the firm’s CEO & Director, Mr. Matthew T. DiCanio M.B.A., MBA serves as its President & CFO.
Institutional Ownership:
Through their ownership of 0.35035 of CON’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, CON reported revenue of $489638000.0 and operating income of $86234000.0. The EBITDA in the recently reported quarter was $101447000.0 and diluted EPS was $0.37.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With CON analysts setting a high price target of 30.0 and a low target of 24.0, the average target price over the next 12 months is 27.5. Based on these targets, CON could surge 55.52% to reach the target high and rise by 24.42% to reach the target low. Reaching the average price target will result in a growth of 42.56% from current levels.
Analysts have provided yearly estimates in a range of $1.5 being high and $1.45 being low. For CON, this leads to a yearly average estimate of $1.47. Based on analyst estimates, the high estimate for the next quarter is $0.32 and the low estimate is $0.28. The average estimate for the next quarter is thus $0.31.
